CONCLUSIONS	Levosimendan improved the haemodynamics in cardiac valve surgery patients with low ejection fraction and/or severe pulmonary arterial hypertension , and facilitated weaning from cardiopulmonary bypass in such high-risk patients when started as a prophylactic agent .\